Evolution of the Average Target: AstraZeneca PLC

Evolution of the Average Target - AstraZeneca PLC

Evolution of the Target Price: AstraZeneca PLC

Evolution of the Target Price - AstraZeneca PLC

Changes in Analyst Recommendations: AstraZeneca PLC

99.gSIEZmdgVfj2HdnMBIGsOnNPGi8WgOWdrLhRM471IOA.tnA8HDImI4jCZYz0cNuZVDohfXkj5KrPxPoQZ9GEeqbGb0ELEFgAyrhxsg~20daefe9a5b1303065454d3192c26278
Oct. 15 RBC Reaffirms AstraZeneca's Outperform Rating Ahead of Q3 Results MT
Oct. 15 AstraZeneca PLC : UBS gives a Buy rating ZD
Oct. 15 AstraZeneca PLC : Gets a Buy rating from RBC ZD
Oct. 14 AstraZeneca PLC : Deutsche Bank reiterates its Neutral rating ZD
Oct. 07 Berenberg Trims AstraZeneca PT, Affirms Outperform Rating MT
Oct. 07 Deutsche Bank ups Glencore, BHP price targets AN
Oct. 07 AstraZeneca PLC : Buy rating from Berenberg ZD
Oct. 07 AstraZeneca PLC : Jefferies gives a Buy rating ZD
Oct. 07 AstraZeneca PLC : Bernstein reaffirms its Buy rating ZD
Oct. 06 Genmab in Good Health, Schneider Lacks Energy Zonebourse
Oct. 06 BofA Forecasts 'In-line' Q3, Unchanged FY26 Outlook for AstraZeneca Amid Oncology Momentum MT
Sep. 30 AstraZeneca PLC : Deutsche Bank reaffirms its Neutral rating ZD
Sep. 29 AstraZeneca's $2 Billion Investment in Summit Therapeutics Seen as 'Win-Win,' UBS Says MT
Sep. 29 Stocks Defy the Pressure Zonebourse
Sep. 29 AstraZeneca PLC : Jefferies keeps its Buy rating ZD
Sep. 29 AstraZeneca PLC : RBC reaffirms its Buy rating ZD
Sep. 29 AstraZeneca PLC : JP Morgan maintains a Buy rating ZD
Sep. 29 AstraZeneca PLC : Deutsche Bank is Neutral ZD
Sep. 18 Berenberg and Deutsche say buy Bytes Technology AN
Sep. 16 AstraZeneca PLC : Gets a Buy rating from UBS ZD
Sep. 16 Oddo BHF cuts Safestore to neutral, cuts target AN
Sep. 16 AstraZeneca PLC : Buy rating from Jefferies ZD
Sep. 16 AstraZeneca PLC : JP Morgan keeps its Buy rating ZD
Sep. 16 AlphaValue/Baader Europe Notes GSK's Plans to Address Upcoming Patent Cliff; Price Target Down MT
Sep. 15 Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+9.87%
+9.83%
-0.31%
+7.65%
+1.71%
+2.68%
+29.22%
-7.35%
+3.93%
Average +6.36%
Weighted average by Cap. +7.00%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
168.27USD
Average target price
208.95USD
Spread / Average Target
+24.17%
High Price Target
262.96USD
Spread / Highest target
+56.27%
Low Price Target
154.83USD
Spread / Lowest Target
-7.99%

Analyst Consensus Detail

Analyst consensus - AstraZeneca PLC

Consensus revision (last 18 months)

Consensus revision (last 18 months) - AstraZeneca PLC
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - AstraZeneca PLC